Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biosci Rep ; 38(5)2018 10 31.
Article in English | MEDLINE | ID: mdl-30126847

ABSTRACT

The current study was designed to investigate effect of copper administration on oxidative damage to the brain in ApoE-/- mice and to explore the putative neuroprotective effects rendered by apolipoprotein E (ApoE). Male C57BL/6 ApoE-/- and wild-type mice were randomly assigned into four groups, ApoE-/- mice wild-type mice treated with either copper or saline. Copper sulphate pentahydrate or saline (200 µl) were administered intragastrically daily for 12 weeks. Expression of malondialdehyde, superoxide dismutase (SOD), hemeoxygenase 1 (HO-1), and NAD(P)H: quinone oxidoreductase 1 (NQO1) were determined by a combination of biochemical assays. The concentration of copper in the brain of C57BL/6 mice and ApoE-/- mice treated by copper significantly increased compared with mice treated by saline (P=0.0099 and P=0.0443). Compared with the C57BL/6 mice treated by copper, the level of the ApoE-/- mice treated by copper was higher (P=0.018). TBARS and SOD activities or the expressions of NQO1 and HO-1 in the brain were not significantly different amongst the four experimental groups of mice. The relative value of NQO1/ß-actin expression in the brain of the ApoE-/- mice was similar in both saline and copper administration experimental groups. However, Western blot analysis showed that NQO1 expression was significantly higher in the ApoE-/- mice brain treated with saline compared with saline treated wild-type mice (P=0.0449). ApoE does not function in protecting the brain from oxidative damage resulting from copper build-up in Wilson's disease, but may play a role in regulating copper accumulation in the brain.


Subject(s)
Apolipoproteins E/genetics , Brain/drug effects , Hepatolenticular Degeneration/genetics , Oxidative Stress/drug effects , Animals , Brain/metabolism , Brain/pathology , Copper/administration & dosage , Gene Expression Regulation/drug effects , Heme Oxygenase-1/genetics , Hepatolenticular Degeneration/pathology , Hepatolenticular Degeneration/prevention & control , Humans , Mice , Mice, Knockout , NAD(P)H Dehydrogenase (Quinone)/genetics , Neuroprotective Agents/metabolism , Oxidative Stress/genetics , Sequence Deletion/genetics , Superoxide Dismutase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...